A switch towards Th2 during serological rebound in children with congenital toxoplasmosis

Clinical and Experimental Immunology

Volumn 117, Issue 3, 1999, Pages 524-528

  Kahi, S ^a   Cozon, G J N ^a   Pinon, J M ^b   Greenland, T ^c   Wallon, M ^a   Al Kurdi, M ^a   Ferrandiz, J ^a   Peyron, F ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

Congenital toxoplasmosis; IgE; IL 4; Interferon gamma; Serological rebound

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; PRIORITY JOURNAL; SCHOOL CHILD; TOXOPLASMA GONDII;

ADULT; ANIMALS; CD4 LYMPHOCYTE COUNT; CHILD; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-4; MICE; RECEPTORS, INTERLEUKIN-2; TH1 CELLS; TH2 CELLS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL; TUMOR CELLS, CULTURED;

EID: 0032783709     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01019.x     Document Type: Article

References (30)

1. 1 Darcy F, Santoro F. Toxoplasmosis. In: Kierszenbaum F, eds. Parasitic infections and the immune system. San Diego: Academic Press Inc, 1994:163-201.
2. 2 Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986; i:254-6.
3. 3 Fortier B, Coignard-Chatain C, Dao A et al. Etude des poussées cliniques évolutives et des rebonds sérologiques d'enfants atteints de toxoplasmose congénitale et suivis durant les 2 premières années de vie. Arch Pédiatr 1997; 4:940-6.
4. 4 Kahi S, Cozon GJN, Greenland T et al. Circulating Toxoplasma gondiispecific antibody-secreting cells in patients with congenital toxoplasmosis. Clin Immunol Immunopathol 1998; 89:23-27.
5. 5 Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
6. 6 O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8:275-83.
7. 7 Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18:263-6.
8. 8 Hunter CA, Roberts CW, Alexander J. Kinetics of cytokine mRNA in the brains of mice with progressive toxoplasmic encephalitis. Eur J Immunol 1992; 22:2317-22.
9. 9 Burke JM, Roberts CW, Hunter CA et al. Temporal differences in the expression of mRNA for IL-10 and IFNγ in the brains and spleens of C57BL/10 mice infected with Toxoplasma gandii. Parasite Immunol 1994; 16:305-14.
10. 10 Gazzinelli RT, Wysocka M, Hieny S et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ cells and accompanied by overproduction of IL-12, IFNγ and TNFα. J Immunol 1996, 157:798-805.
11. 11 Bohne W, Heesemann J, Gross U. Induction of bradyzoile specific Toxoplasma gondii antigens in gamma-interferon-treated mouse macrophages. Infect Immun 1993; 61:1141-5.
12. 12 Saavedra R, Herion P. Human T-cell clones against Toxoplasma gondii: production of interferon-γ, interleukin-2, and strain cross-reactivity. Parasitol Res 1991; 77:379-85.
13. 13 Däubener W, MacKenzie C, Hadding U. Establishment of T-helper type 1-and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones. Immunology 1995; 86:79-84.
14. 14 Prigione I, Facchetti P, Ghiotto F et al. Toxoplama gondii-specific CD4 + T cell clones from healthy, latently infected humans display a T helper (TH) 0 profile of cytokine secretion. Eur J Immunol 1995; 25:1298-305.
15. 15 Gomez Marin JE, Pinon JM, Bonhomme A et al. Does human toxoplasmosis involve an imbalance in T1/T2 cytokines? Med Hypotheses 1997; 48:161-9.
16. 16 Kahi S, Cozon GIN, Greenland T et al. A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans. Clin Diagn Lab Immunol 1998; 5:745-8.
17. 17 Pinon JM, Toubas D, Marx C et al. Detection of specific immunoglobulin E in patients with toxoplasmosis. J Clin Microbiol 1990; 28:1739-43.
18. 18 Lyte M. In vitro production of interleukin-2 by lymphocytes in whole blood and isolated culture. J Clin Lab Immunol 1988; 26:189-93.
19. 19 Elsässer-Beile U, Von Kleist S, Gallati H. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J Immunol Methods 1991; 139:191-5.
20. 20 Petrovsky N, Harrison LC. Cytokine-based human whole blood assay for the detection of antigen-reactive T cells. J Immunol Methods 1995; 186:37-46.
21. 21 Weir RE, Morgan AR, Britton WJ et al. Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immunoepidemiological field studies of leprosy immunity. J Immunol Methods 1994; 176:93-101.
22. 22 Pene J, Rousset F, Briere F et al. IgE production by normal human lymphocytes is induced by IL-4 and suppressed by interferons and prostaglandin E2. Proc Natl Acad Sci USA 1988; 85:6880-4.
23. 23 Bessieres MH, Swierczynski B, Cassaing S et al. Role of IFN-γ, TNF-α, IL-4 and IL-10 in the regulation of experimental Toxoplasma gondii infection. J Eukaryot Microbiol 1997; 44:87S.
24. 24 Villard O, Candolfi E, Despringre JL et al. Protective effect of low doses of an anti-IL-4 monoclonal antibody in a murine model of acute toxoplasmosis. Parasite Imnunol 1995; 17:233-6.
25. 25 Roberts CW, Ferguson DJP, Jebbari H et al. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun 1996; 64:897-904.
26. 26 Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996; 271:1728-30.
27. 27 Villena I, Aubert D, Leroux B et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Scand J Infect Dis 1998; 30:295-300.
28. 28 Sklenar I, Jones TC, Alkan S et al. Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets. J Infect Dis 1986; 153:315-24.
29. 29 Misra N, Murtaza A, Walker B et al. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 1995; 86:97-103.
30. 30 Ribeiro-De-Jesus A, Almeida RP, Lessa H et al. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998; 31:143-8.